David Rothbart, MD, a spine surgeon with Spine Team Texas in Southlake, discusses the biggest challenges his practice has faced and where he sees the biggest opportunity in the future.
Author: Staff
New York City-based Hospital for Special Surgery researchers launched a clinical trial to assess the effects of Organogenesis' ReNu on knee function.
Here are 12 spine and neurosurgeons making headlines.
Roger Härtl, MD, is a board-certified neurosurgeon at New York City-based Weill Cornell Medicine.
John W. Shimkus, MD, 65, passed away, The Evening Tribune reports.
Medacta International received FDA 510(k) clearance for its Mpact 3D Metal Implants and Augments 3D Metal as enhancements to its Mpact System for primary to complex hip revision procedures.
A stem cell provider registry program will improve the quality of treatments, wrote Fabio Rossi, MD, PhD, and Judy Illes, PhD, in an op-ed in the Vancouver Sun.
Baxter International received FDA 510(k) clearance for its Altapore Bioactive Bone Graft for spinal fusion.
An inability to fully utilize manganese may cause some cases of severe adolescent idiopathic scoliosis, according to a study in Nature Communications.
Four new studies indicate that the U.S. healthcare system is progressing toward a patient-centered, comprehensive and collaborative care model.
